Step Therapy Information... 4 Prior Authorization Information ACE Inhibitors and ACE Inhibitor Combinations...60 Acne Therapy...

Size: px
Start display at page:

Download "Step Therapy Information... 4 Prior Authorization Information ACE Inhibitors and ACE Inhibitor Combinations...60 Acne Therapy..."

Transcription

1 Step Therapy Information... 4 Prior Authorization Information ACE Inhibitors and ACE Inhibitor Combinations...60 Acne Therapy...62 Acne Therapy Topical...64 Alcoholism Treatment Agents Analgesic Narcotic Agonist Combinations Analgesic Narcotic Agonists and Combinations Analgesic, Anti-inflammatory or Antipyretic Analgesic, Anti-inflammatory or Antipyretic - Non-Narcotic Analgesics - Narcotic Androgen-Anabolic Anesthetics Angina Therapy...74 Angiotensin II Receptor Blocker (ARBs) and ARB Cominations...75 Anorectal Preparations Anti-Infective Agents...78 Antiarrhythmics Antibacterial Agents...80 Anticoagulants Anticonvulsants...85 Antidepressant Combinations Antidepressants Antidiarrheals...86 Antidotes and other Reversal Agents Antiemetic - Antihistamines and Antihistamine Combinations Antiemetics Antifungals Antihyperlipidemic Agents Other...88 Antihyperlipidemic Combinations...89 Antihyperlipidemics Antihypertensive Therapy Agents Antihypertensive Therapy Combinations Antimycobacterial Agents Antineoplastic - Antimetabolites...92 Antineoplastic - Protein-Tyrosine Kinase Inhibitors Antineoplastic - Systemic Enzyme Inhibitors Antineoplastic - Topoisomerase Inhibitors Antineoplastics...93 Antiparasitics...97 Antiparkinson Therapy...97 Antiparkinson s Adjuvants Antiprotozoal Antiprotozoal-Antibacterial Agents Antipsychotic - Atypical Agents, General Antipsychotic - Dopamine Antagonists Antipsychotics (Neuroleptics) Antiretroviral - Entry Inhibitors Antiretrovirals Antiseptics and Disinfectants Antithyroid Agents Antitussive-Antihistamine Combinations Antitussive-Antihistamine-Decongestant Combinations, All Antivirals Asthma/COPD Therapy Agents Beta Adrenergic Blockers BetaLactam Antibiotics Bone Resorption Inhibitors Bone Resorption Inhibitors - Bisphosphonates and Combinations Calcium and Bone Metabolism Regulators Calcium Channel Blockers Calcium Channel Blockers and Combinations Cardiovascular Sympathomimetics and Combinations Cardiovascular Therapy Agents Central Nervous System Agents Chemical Dependency, Agents to Treat Chemicals-Pharmaceutical Adjuvants CNS Stimulants Cognitive Disorder Therapy

2 Contraceptives Contraceptives Intravaginal Contraceptives Oral Contraceptives Transdermal Corticosteroids Cough and Cold or Allergy Combinations Cystic Fibrosis Therapy Agents Dental-Periodontal Products Dermatological Dermatological - Anti-infective Combinations Dermatological - Anti-infectives Dermatological - Antiparasitics and Combinations Dermatological - Antipsoriatic Agents Systemic Dermatological - Antipsoriatics Dermatological - Dermatitis or Eczema Agents Dermatological - Glucocorticoids and Combinations Dermatological - Topical Local Anesthetics and Combinations Diabetic Therapy Diagnostic Agents Digestive Aids Disease Modifying Anti-Rheumatoid Drugs (DMARD) Diuretic - Potassium Sparing (Single Agent), All Diuretic - Potassium Sparing Diuretics and Combinations Diuretics Drugs to treat Erectile Dysfunction Eating Disorder Therapy Electrolyte Balance-Nutritional Products Endocrine Estrogen Combinations Estrogens and Combinations Fertility Enhancers Folate Antagonist Antibiotics Gastrointestinal Antispasmodics Gastrointestinal Therapy Agents Genitourinary Therapy GI Antispasmodic Combinations Gout and Hyperuricemia Therapy Hematological Agents Hematopoietic Agents Hematopoietic Agents - Hematopoietic Growth Factors Hemostatics Hepatitis Agents Hepatitis C Treatment Agents Immunosuppressive Agents Influenza Agents Insulin - Human and Analogs, Single Agent Insulin - Human and Analogs, Single Agents, and Combinations Laxative Combinations Laxatives Locomotor System Medical Supplies and DME - Diabetic Supplies Medical Supplies and Durable Medical Equipment (DME) Menopausal Symptoms Suppressant Metabolic Disease Enzyme Replacement Agents Metabolic Modifiers Migraine Therapy Minerals and Electrolytes Minerals and Electrolytes - Potassium and Combinations Mouth-Throat-Dental - Preparations Multiple Sclerosis Agents Musculoskeletal Therapy Agents Narcolepsy and Cataplexy Therapy Agents Nasal Preparations Neuromuscular Therapy Agents NSAID Analgesics NSAID Analgesics and NSAID Combinations Ophthalmic - Anti-infectives Ophthalmic - Intraocular Pressure Reducing Agents Ophthalmic Agents

3 Ophthalmic Combinations Oral Antidiabetic Agents Otic Otic - Anti-infectives Oxytocics Passive Immunizing Agents Penicillin Antibiotic Combinations Peptic Ulcer - H. Pylori Agents Peptic Ulcer Therapy Pharmaceutical Adjuvants Prolactin Inhibitors Prostatic Hypertrophy Agents Pulmonary Antihypertensive Agents Quinolone Antibiotics Renin-Angiotensin-Aldosterone System (RAAS) Blocking Agents Respiratory Therapy Agents Salicylate Analgesic and Salicylate Combinations Sedative-Hypnotics Skeletal Muscle Relaxant Combinations Smoking Deterrents and Combinations Smoking Deterrents, Systemic Thyroid Therapy Urinary Anti-infective Combinations Urinary Anti-infectives Urinary Antispasmodics Urinary ph Modifiers Vaccine Viral - Hepatitis Vaccines Vaccines - Bacterial Vaccines - Viral Vaginal Anti-infectives Vaginal Antibacterials Vaginal Antifungals Vaginal Products Vitamin Combinations Vitamins Vitamins - Water Soluble Analgesic, Anti-inflammatory or Antipyretic - Non-Narcotic Antacids and Combinations Contraceptives Contraceptives Intravaginal Gastrointestinal Therapy Agents Hematological Agents Insulin - Human and Analogs, Single Agent Insulin - Human and Analogs, Single Agents, and Combinations Medical Supplies and DME - Contraceptives Medical Supplies and DME - Diabetic Supplies Medical Supplies and DME-Glucose Monitoring and Insulin Admin Supplies Medical Supplies and Durable Medical Equipment (DME) Minerals and Electrolytes Smoking Deterrents and Combinations Vitamins Vitamins - Water Soluble

4 Step Therapy Information Gastrointestinal Therapy Agents SANCUSO 3.1 MG/24 HR PATCH SANCUSO PA,QL,ST See Prior Authorization Criteria, Requires trial and failure of ondansetron or granisetron ZUPLENZ 4 MG SOLUBLE FILM ZUPLENZ PA,ST See Prior Authorization Criteria, Requires trial and failure of ondansetron or granisetron ZUPLENZ 8 MG SOLUBLE FILM ZUPLENZ PA,ST See Prior Authorization Criteria, Requires trial and failure of ondansetron or granisetron ANZEMET 100 MG TABLET ANZEMET PA,QL,ST,SP PA Required, Requires trial and failure of ondansetron or granisetron ANZEMET 50 MG TABLET ANZEMET PA,QL,ST,SP PA Required, Requires trial and failure of ondansetron or granisetron Genitourinary Therapy GELNIQUE 10% GEL PUMP GELNIQUE QL,ST Requires trial and failure of oxybutynin, tolterodine or trospium GELNIQUE 10% GEL SACHETS GELNIQUE QL,ST Requires trial and failure of oxybutynin, tolterodine or trospium OXYTROL 3.9 MG/24HR PATCH OXYTROL QL,ST Requires trial and failure of oxybutynin, tolterodine or trospium RAPAFLO 4 MG CAPSULE RAPAFLO QL,ST Requires trial and failure of finasteride, tamsulosin or alfuzosin RAPAFLO 8 MG CAPSULE RAPAFLO QL,ST Requires trial and failure of finasteride, tamsulosin or alfuzosin Gout and Hyperuricemia Therapy ULORIC 40 MG TABLET ULORIC QL,ST Requires treatment failure, intolerance or contraindication with generic allopurinol (Zyloprim). ULORIC 80 MG TABLET ULORIC QL,ST Requires treatment failure, intolerance or contraindication with generic allopurinol (Zyloprim). Menopausal Symptoms Suppressant PAROXETINE MESYLATE 7.5 MG CAP PAROXETINE MESYLATE QL,ST Requires trial/failure of generic paroxetine (Paxil) and generic venlafaxine (Effexor, Effexor XR or venlafaxine ER). BRISDELLE 7.5 MG CAPSULE BRISDELLE QL,ST Requires trial/failure of generic paroxetine (Paxil) and generic venlafaxine (Effexor, Effexor XR or venlafaxine ER). 4

5 Step Therapy Information Migraine Therapy SUMAVEL DOSEPRO 4 MG/0.5 ML SUMAVEL DOSEPRO QL,ST Requires trial and failure of both options generic sumatriptan injection (Imitrex) and generic rizatriptan (Maxalt MLT). SUMAVEL DOSEPRO 6 MG/0.5 ML SUMAVEL DOSEPRO QL,ST Requires trial and failure of both options generic sumatriptan injection (Imitrex) and generic rizatriptan (Maxalt MLT). Musculoskeletal Therapy Agents AMRIX ER 15 MG CAPSULE AMRIX ST Approval requires previous trial and failure of generic immediaterelease cyclobenzaprine (Flexeril). AMRIX ER 30 MG CAPSULE AMRIX ST Approval requires previous trial and failure of generic immediaterelease cyclobenzaprine (Flexeril). Nasal Preparations DYMISTA NASAL SPRAY DYMISTA PA,ST See Prior Authorization Criteria, Requires trial and failure/ intolerance of 2 of the following intranasal steroids: 1. Generic fluticasone (Flonase). 2. Generic flunisolide (Nasarel). 3. Generic triamcinolone (Nasacort AQ). Ophthalmic Agents ALOCRIL 2% EYE DROPS ALOCRIL ST Requires trial and failure of ketotifen or another generic agent ALOMIDE 0.1% EYE DROPS ALOMIDE ST Requires trial and failure of ketotifen or another generic agent LUMIGAN 0.01% EYE DROPS LUMIGAN ST Requires trial and failure of latanoprost or travoprost TRAVATAN Z 0.004% EYE DROP TRAVATAN Z ST Requires trial and failure of latanoprost or travoprost BEPREVE 1.5% EYE DROPS BEPREVE ST Requires trial and failure of ketotifen or another generic agent EMADINE 0.05% EYE DROPS EMADINE ST Requires trial and failure of ketotifen or another generic agent LASTACAFT 0.25% EYE DROPS LASTACAFT ST Requires trial and failure of ketotifen or another generic agent ZIOPTAN % EYE DROPS ZIOPTAN ST Requires trial and failure of latanoprost or travoprost Oral Antidiabetic Agents ALOGLIPTIN-METFORMIN ALOGLIPTIN-METFORMIN QL,ST Requires trial and failure of Januvia and Onglyza ALOGLIPTIN-METFORMIN ALOGLIPTIN-METFORMIN QL,ST Requires trial and failure of Januvia and Onglyza 5

6 Step Therapy Information Oral Antidiabetic Agents ALOGLIPTIN-PIOGLIT MG ALOGLIPTIN-PIOGLITAZONE QL,ST Requires trial and failure of Januvia and Onglyza ALOGLIPTIN-PIOGLIT MG ALOGLIPTIN-PIOGLITAZONE QL,ST Requires trial and failure of Januvia and Onglyza ALOGLIPTIN-PIOGLIT MG ALOGLIPTIN-PIOGLITAZONE QL,ST Requires trial and failure of Januvia and Onglyza ALOGLIPTIN-PIOGLIT MG TB ALOGLIPTIN-PIOGLITAZONE QL,ST Requires trial and failure of Januvia and Onglyza ALOGLIPTIN-PIOGLIT MG TB ALOGLIPTIN-PIOGLITAZONE QL,ST Requires trial and failure of Januvia and Onglyza ALOGLIPTIN-PIOGLIT MG TB ALOGLIPTIN-PIOGLITAZONE QL,ST Requires trial and failure of Januvia and Onglyza INVOKAMET 150-1,000 MG TABLET INVOKAMET PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent INVOKAMET MG TABLET INVOKAMET PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent INVOKAMET 50-1,000 MG TABLET INVOKAMET PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent INVOKAMET MG TABLET INVOKAMET PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent INVOKAMET XR 150-1,000 MG TAB INVOKAMET XR ST Requires trial and failure of metformin or a metformin combination agent INVOKAMET XR MG TABLET INVOKAMET XR ST Requires trial and failure of metformin or a metformin combination agent INVOKAMET XR 50-1,000 MG TAB INVOKAMET XR ST Requires trial and failure of metformin or a metformin combination agent INVOKAMET XR MG TABLET INVOKAMET XR ST Requires trial and failure of metformin or a metformin combination agent JANUMET 50-1,000 MG TABLET JANUMET ST Requires trial and failure of metformin or a metformin combination agent JANUMET MG TABLET JANUMET ST Requires trial and failure of metformin or a metformin combination agent JANUMET XR 100-1,000 MG TABLET JANUMET XR QL,ST Requires trial and failure of metformin or a metformin combination agent JANUMET XR 50-1,000 MG TABLET JANUMET XR QL,ST Requires trial and failure of metformin or a metformin combination agent 6

7 Step Therapy Information Oral Antidiabetic Agents JANUMET XR MG TABLET JANUMET XR QL,ST Requires trial and failure of metformin or a metformin combination agent JENTADUETO 2.5 MG-1,000 MG TAB JENTADUETO QL,ST Requires trial and failure of metformin or a metformin combination agent JENTADUETO 2.5 MG-500 MG TAB JENTADUETO QL,ST Requires trial and failure of metformin or a metformin combination agent JENTADUETO 2.5 MG-850 MG TAB JENTADUETO QL,ST Requires trial and failure of metformin or a metformin combination agent JENTADUETO XR 2.5 MG-1,000 MG JENTADUETO XR ST Requires trial and failure of metformin or a metformin combination agent JENTADUETO XR 5 MG-1,000 MG TB JENTADUETO XR ST Requires trial and failure of metformin or a metformin combination agent KOMBIGLYZE XR 2.5-1,000 MG TAB KOMBIGLYZE XR ST Requires trial and failure of metformin or a metformin combination agent KOMBIGLYZE XR 5-1,000 MG TAB KOMBIGLYZE XR ST Requires trial and failure of metformin or a metformin combination agent KOMBIGLYZE XR MG TABLET KOMBIGLYZE XR ST Requires trial and failure of metformin or a metformin combination agent SYNJARDY ,000 MG TABLET SYNJARDY PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent SYNJARDY MG TABLET SYNJARDY PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent SYNJARDY 5-1,000 MG TABLET SYNJARDY PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent SYNJARDY MG TABLET SYNJARDY PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent SYNJARDY XR 10-1,000 MG TABLET SYNJARDY XR ST Requires trial and failure of metformin or a metformin combination agent SYNJARDY XR ,000 MG TAB SYNJARDY XR ST Requires trial and failure of metformin or a metformin combination agent SYNJARDY XR 25-1,000 MG TABLET SYNJARDY XR ST Requires trial and failure of metformin or a metformin combination agent 7

8 Step Therapy Information Oral Antidiabetic Agents SYNJARDY XR 5-1,000 MG TABLET SYNJARDY XR ST Requires trial and failure of metformin or a metformin combination agent XIGDUO XR 10 MG-1,000 MG TAB XIGDUO XR PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent XIGDUO XR 10 MG-500 MG TABLET XIGDUO XR PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent XIGDUO XR 5 MG-1,000 MG TABLET XIGDUO XR PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent XIGDUO XR 5 MG-500 MG TABLET XIGDUO XR PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent Angiotensin II Receptor Blocker (ARBs) and ARB Cominations EDARBYCLOR MG TABLET EDARBYCLOR QL,ST Requires documentation that the member has experienced failure of or intolerance to a generic Angiotensin II Receptor Blocker (ARB) and Benicar/HCT. EDARBYCLOR MG TABLET EDARBYCLOR QL,ST Requires documentation that the member has experienced failure of or intolerance to a generic Angiotensin II Receptor Blocker (ARB) and Benicar/HCT. Peptic Ulcer Therapy ESOMEPRAZOLE MAG DR 20 MG CAP ESOMEPRAZOLE MAGNESIUM ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). ESOMEPRAZOLE MAG DR 40 MG CAP ESOMEPRAZOLE MAGNESIUM ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). 8

9 Step Therapy Information Peptic Ulcer Therapy OMEPRAZOLE-BICARB 40-1,680 PKT OMEPRAZOLE-BICARB 20-1,100 CAP OMEPRAZOLE-BICARB 20-1,680 PKT OMEPRAZOLE-BICARB 40-1,100 CAP OMEPRAZOLE-SODIUM BICARBONATE OMEPRAZOLE-SODIUM BICARBONATE OMEPRAZOLE-SODIUM BICARBONATE OMEPRAZOLE-SODIUM BICARBONATE ST QL,ST ST QL,ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). ACIPHEX SPRINKLE DR 10 MG CAP ACIPHEX SPRINKLE QL,ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). ACIPHEX SPRINKLE DR 5 MG CAP ACIPHEX SPRINKLE QL,ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). DEXILANT DR 30 MG CAPSULE DEXILANT ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). DEXILANT DR 60 MG CAPSULE DEXILANT ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). 9

10 Step Therapy Information Peptic Ulcer Therapy ESOMEPRAZOLE DR MG CAP ESOMEPRAZOLE STRONTIUM ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). ESOMEPRAZOLE DR 49.3 MG CAP ESOMEPRAZOLE STRONTIUM ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). NEXIUM DR 10 MG PACKET NEXIUM ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). NEXIUM DR 2.5 MG PACKET NEXIUM ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). NEXIUM DR 20 MG PACKET NEXIUM ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). NEXIUM DR 40 MG PACKET NEXIUM ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). NEXIUM DR 5 MG PACKET NEXIUM ST Requires failure of or intolerance to all generic alternatives: generic omeprazole (Prilosec) and generic pantoprazole (Protonix) and generic lansoprazole (Prevacid/ Prevacid Solutab) and generic rabeprazole (Aciphex). Renin-Angiotensin-Aldosterone System (RAAS) Blocking Agents 10

11 Step Therapy Information Renin-Angiotensin-Aldosterone System (RAAS) Blocking Agents EDARBI 40 MG TABLET EDARBI QL,ST Requires documentation that the member has experienced failure of or intolerance to a generic Angiotensin II Receptor Blocker (ARB) and Benicar/HCT. EDARBI 80 MG TABLET EDARBI QL,ST Requires documentation that the member has experienced failure of or intolerance to a generic Angiotensin II Receptor Blocker (ARB) and Benicar/HCT. Respiratory Therapy Agents BUDESONIDE 32 MCG NASAL SPRAY BUDESONIDE QL,ST Requires trial and failure/ intolerance of 2 of the following intranasal steroids: 1. Generic fluticasone (Flonase). 2. Generic flunisolide (Nasarel). 3. Generic triamcinolone (Nasacort AQ). MOMETASONE FUROATE 50 MCG SPRY MOMETASONE FUROATE QL,ST Requires trial and failure/ intolerance of 2 of the following intranasal steroids: 1. Generic fluticasone (Flonase). 2. Generic flunisolide (Nasarel). 3. Generic triamcinolone (Nasacort AQ). BECONASE AQ 0.042% SPRAY BECONASE AQ QL,ST Requires trial and failure/ intolerance of 2 of the following intranasal steroids: 1. Generic fluticasone (Flonase). 2. Generic flunisolide (Nasarel). 3. Generic triamcinolone (Nasacort AQ). OMNARIS 50 MCG NASAL SPRAY OMNARIS QL,ST Requires trial and failure/ intolerance of 2 of the following intranasal steroids: 1. Generic fluticasone (Flonase). 2. Generic flunisolide (Nasarel). 3. Generic triamcinolone (Nasacort AQ). QNASL 80 MCG NASAL SPRAY QNASL QL,ST Requires trial and failure/ intolerance of 2 of the following intranasal steroids: 1. Generic fluticasone (Flonase). 2. Generic flunisolide (Nasarel). 3. Generic triamcinolone (Nasacort AQ). QNASL CHILDREN S 40 MCG SPRAY QNASL CHILDREN QL,ST Requires trial and failure/ intolerance of 2 of the following intranasal steroids: 1. Generic fluticasone (Flonase). 2. Generic flunisolide (Nasarel). 3. Generic triamcinolone (Nasacort AQ). VERAMYST 27.5 MCG NASAL SPRAY VERAMYST QL,ST Requires trial and failure/ intolerance of 2 of the following intranasal steroids: 1. Generic fluticasone (Flonase). 2. Generic flunisolide (Nasarel). 3. Generic triamcinolone (Nasacort AQ). 11

12 Step Therapy Information Respiratory Therapy Agents ZETONNA 37 MCG NASAL SPRAY ZETONNA QL,ST Requires trial and failure/ intolerance of 2 of the following intranasal steroids: 1. Generic fluticasone (Flonase). 2. Generic flunisolide (Nasarel). 3. Generic triamcinolone (Nasacort AQ). Sedative-Hypnotics ZOLPIDEM TART 1.75 MG TAB SL ZOLPIDEM TARTRATE QL,ST Requires trial and failure, or intolerance to generic zolpidem extended release (Ambien CR) and generic zaleplon (Sonata). Also, coverage will not be approved for combination therapy with other sedative hypnotics. ZOLPIDEM TART 3.5 MG TABLET SL ZOLPIDEM TARTRATE QL,ST Requires trial and failure, or intolerance to generic zolpidem extended release (Ambien CR) and generic zaleplon (Sonata). Also, coverage will not be approved for combination therapy with other sedative hypnotics. SILENOR 6 MG TABLET SILENOR QL,ST Requires treatment failure of 3 out of 4 of the following: immediaterelease zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), or trazodone (Desyrel). ZOLPIMIST 5 MG ORAL SPRAY ZOLPIMIST ST Requires treatment failure of 3 out of 4 of the following: immediaterelease zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), or trazodone (Desyrel). BELSOMRA 10 MG TABLET BELSOMRA QL,ST Requires treatment failure of 3 out of 4 of the following: immediaterelease zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), or trazodone (Desyrel). BELSOMRA 15 MG TABLET BELSOMRA QL,ST Requires treatment failure of 3 out of 4 of the following: immediaterelease zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), or trazodone (Desyrel). BELSOMRA 20 MG TABLET BELSOMRA QL,ST Requires treatment failure of 3 out of 4 of the following: immediaterelease zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), or trazodone (Desyrel). BELSOMRA 5 MG TABLET BELSOMRA QL,ST Requires treatment failure of 3 out of 4 of the following: immediaterelease zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), or trazodone (Desyrel). 12

13 Step Therapy Information Sedative-Hypnotics EDLUAR 10 MG SL TABLET EDLUAR QL,ST Requires treatment failure of 3 out of 4 of the following: immediaterelease zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), or trazodone (Desyrel). EDLUAR 5 MG SL TABLET EDLUAR QL,ST Requires treatment failure of 3 out of 4 of the following: immediaterelease zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), or trazodone (Desyrel). SILENOR 3 MG TABLET SILENOR QL,ST Requires treatment failure of 3 out of 4 of the following: immediaterelease zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), or trazodone (Desyrel). ACE Inhibitors and ACE Inhibitor Combinations PRESTALIA 14 MG-10 MG TABLET PRESTALIA QL,ST Coverage requires the following: 1. Trial and failure of a preferred ACE inhibitor and calcium channel blocker combination (example: generic Lotrel (amlodipine/ benazepril)). 2. Trial and failure of the individual agents, perindopril and amlodipine used in combination at doses similar to the combination product. PRESTALIA 3.5 MG-2.5 MG TABLET PRESTALIA QL,ST Coverage requires the following: 1. Trial and failure of a preferred ACE inhibitor and calcium channel blocker combination (example: generic Lotrel (amlodipine/ benazepril)). 2. Trial and failure of the individual agents, perindopril and amlodipine used in combination at doses similar to the combination product. PRESTALIA 7 MG-5 MG TABLET PRESTALIA QL,ST Coverage requires the following: 1. Trial and failure of a preferred ACE inhibitor and calcium channel blocker combination (example: generic Lotrel (amlodipine/ benazepril)). 2. Trial and failure of the individual agents, perindopril and amlodipine used in combination at doses similar to the combination product. Acne Therapy FABIOR 0.1% FOAM FABIOR QL,ST Requires trial and failure with the preferred alternatives generic adapalene (Differin) and generic tretinoin (Retin-A, Avita). 13

14 Step Therapy Information Acne Therapy Topical ONEXTON GEL PUMP ONEXTON QL,ST Coverage requires trial of all of the following: 1. The individuals agents in combination (topical clindamycin plus benzoyl peroxide) 2. Duac(g) and 3. Benzaclin(g) Antiparkinson Therapy RYTARY ER MG-95 MG CAP RYTARY QL,ST Coverage requires a trial and failure of generic Sinemet immediate release or Sinemet CR. RYTARY ER MG-145 MG CAP RYTARY QL,ST Coverage requires a trial and failure of generic Sinemet immediate release or Sinemet CR. RYTARY ER MG-195 MG CAP RYTARY QL,ST Coverage requires a trial and failure of generic Sinemet immediate release or Sinemet CR. RYTARY ER MG-245 MG CAP RYTARY QL,ST Coverage requires a trial and failure of generic Sinemet immediate release or Sinemet CR. Antipsychotic - Atypical Agents, General FANAPT 1 MG TABLET FANAPT ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). FANAPT 10 MG TABLET FANAPT ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). FANAPT 12 MG TABLET FANAPT ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). FANAPT 2 MG TABLET FANAPT ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). FANAPT 4 MG TABLET FANAPT ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). FANAPT 6 MG TABLET FANAPT ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). FANAPT 8 MG TABLET FANAPT ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). 14

15 Step Therapy Information Antipsychotic - Atypical Agents, General FANAPT TITRATION PACK FANAPT ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). LATUDA 120 MG TABLET LATUDA QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). LATUDA 20 MG TABLET LATUDA QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). LATUDA 40 MG TABLET LATUDA QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). LATUDA 60 MG TABLET LATUDA QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). LATUDA 80 MG TABLET LATUDA QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). REXULTI 0.25 MG TABLET REXULTI QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. REXULTI 0.5 MG TABLET REXULTI QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. 15

16 Step Therapy Information Antipsychotic - Atypical Agents, General REXULTI 1 MG TABLET REXULTI QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. REXULTI 2 MG TABLET REXULTI QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. REXULTI 3 MG TABLET REXULTI QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. REXULTI 4 MG TABLET REXULTI QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. SAPHRIS 10 MG TAB SUBLINGUAL BLACK CHERRY SAPHRIS PA,QL,ST PA Required, Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). 16

17 Step Therapy Information Antipsychotic - Atypical Agents, General SAPHRIS 5 MG TAB SUBLINGUAL BLACK CHERRY SAPHRIS PA,QL,ST PA Required, Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). SEROQUEL XR 150 MG TABLET SEROQUEL XR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. SEROQUEL XR 200 MG TABLET SEROQUEL XR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. SEROQUEL XR 300 MG TABLET SEROQUEL XR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. SEROQUEL XR 400 MG TABLET SEROQUEL XR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. 17

18 Step Therapy Information Antipsychotic - Atypical Agents, General SEROQUEL XR 50 MG TABLET SEROQUEL XR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone), one of which must be generic aripiprazole (Abilify). Or For a diagnosis of Major Depressive Disorder, requires a trial of an antidepressant in combination with a generic aripiprazole (Abilify), and documentation that Rexulti will be used adjunctively with an antidepressant. VERSACLOZ 50 MG/ML SUSPENSION VERSACLOZ ST Requires treatment failure or intolerance to clozapine tablets and clozapine ODT unless the member is unable to take both formulations VRAYLAR 1.5 MG CAPSULE VRAYLAR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). VRAYLAR 1.5 MG-3 MG PACK VRAYLAR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). VRAYLAR 3 MG CAPSULE VRAYLAR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). VRAYLAR 4.5 MG CAPSULE VRAYLAR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). VRAYLAR 6 MG CAPSULE VRAYLAR QL,ST Requires a trial of two generic antipsychotics (aripiprazole, clozapine, risperidone, quetiapine, olanzapine, ziprasidone). Antivirals SITAVIG 50 MG BUCCAL TABLET SITAVIG PA,ST See Prior Authorization Criteria, Coverage requires trial and failure of generic oral acyclovir (Zovirax) and generic valacyclovir (Valtrex). Beta Adrenergic Blockers BYSTOLIC 10 MG TABLET BYSTOLIC ST Requires trial and failure of a generic beta blocker BYSTOLIC 2.5 MG TABLET BYSTOLIC ST Requires trial and failure of a generic beta blocker BYSTOLIC 20 MG TABLET BYSTOLIC ST Requires trial and failure of a generic beta blocker 18

19 Step Therapy Information Beta Adrenergic Blockers BYSTOLIC 5 MG TABLET BYSTOLIC ST Requires trial and failure of a generic beta blocker Bone Resorption Inhibitors RISEDRONATE SOD DR 35 MG TAB RISEDRONATE SODIUM DR QL,ST Requires documentation that the member has tried and failed or not tolerated treatment with generic alendronate (Fosamax), or generic ibandronate (Boniva). RISEDRONATE SODIUM 30 MG TAB RISEDRONATE SODIUM QL,ST Requires documentation that the member has tried and failed or not tolerated treatment with generic alendronate (Fosamax), or generic ibandronate (Boniva). RISEDRONATE SODIUM 30 MG TABLET RISEDRONATE SODIUM QL,ST Requires documentation that the member has tried and failed or not tolerated treatment with generic alendronate (Fosamax), or generic ibandronate (Boniva). RISEDRONATE SODIUM 35 MG TAB RISEDRONATE SODIUM QL,ST Requires documentation that the member has tried and failed or not tolerated treatment with generic alendronate (Fosamax), or generic ibandronate (Boniva). RISEDRONATE SODIUM 35 MG TABLET RISEDRONATE SODIUM QL,ST Requires documentation that the member has tried and failed or not tolerated treatment with generic alendronate (Fosamax), or generic ibandronate (Boniva). RISEDRONATE SODIUM 5 MG TABLET RISEDRONATE SODIUM QL,ST Requires documentation that the member has tried and failed or not tolerated treatment with generic alendronate (Fosamax), or generic ibandronate (Boniva). BINOSTO 70 MG TABLET EFF BINOSTO QL,ST Requires documentation that the member has tried and failed or not tolerated treatment with generic alendronate (Fosamax), or generic ibandronate (Boniva). Bone Resorption Inhibitors - Bisphosphonates and Combinations FOSAMAX PLUS D 70 MG-2,800 UNITS FOSAMAX PLUS D QL,ST Requires documentation that the member has tried and failed or not tolerated treatment with generic alendronate (Fosamax), or generic ibandronate (Boniva). FOSAMAX PLUS D 70 MG-5,600 UNITS FOSAMAX PLUS D QL,ST Requires documentation that the member has tried and failed or not tolerated treatment with generic alendronate (Fosamax), or generic ibandronate (Boniva). 19

20 Step Therapy Information Cardiovascular Therapy Agents CARDURA XL 4 MG TABLET CARDURA XL ST Requires trial and failure of finasteride, tamsulosin or alfuzosin CARDURA XL 8 MG TABLET CARDURA XL ST Requires trial and failure of finasteride, tamsulosin or alfuzosin Central Nervous System Agents DESVENLAFAXINE ER 50 MG TABLET DESVENLAFAXINE ER QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. APLENZIN ER 174 MG TABLET APLENZIN ST Requires trial and failure of generic bupropion APLENZIN ER 348 MG TABLET APLENZIN ST Requires trial and failure of generic bupropion APLENZIN ER 522 MG TABLET APLENZIN ST Requires trial and failure of generic bupropion APTIOM 200 MG TABLET APTIOM PA,QL,ST PA Required, Coverage of the requested drug is provided when all of the following are met: 1. Member is >= 18 years of age. 2. Adjunctive therapy in partial-onset epilepsy. 3. Member has experienced treatment failure or intolerance to at least 3 generic alternatives for the treatment of partial-onset seizures or 4. Member is stable on Aptiom APTIOM 400 MG TABLET APTIOM PA,QL,ST PA Required, Coverage of the requested drug is provided when all of the following are met: 1. Member is >= 18 years of age. 2. Adjunctive therapy in partial-onset epilepsy. 3. Member has experienced treatment failure or intolerance to at least 3 generic alternatives for the treatment of partial-onset seizures or 4. Member is stable on Aptiom APTIOM 600 MG TABLET APTIOM PA,QL,ST PA Required, Coverage of the requested drug is provided when all of the following are met: 1. Member is >= 18 years of age. 2. Adjunctive therapy in partial-onset epilepsy. 3. Member has experienced treatment failure or intolerance to at least 3 generic alternatives for the treatment of partial-onset seizures or 4. Member is stable on Aptiom 20

21 Step Therapy Information Central Nervous System Agents APTIOM 800 MG TABLET APTIOM PA,QL,ST PA Required, Coverage of the requested drug is provided when all of the following are met: 1. Member is >= 18 years of age. 2. Adjunctive therapy in partial-onset epilepsy. 3. Member has experienced treatment failure or intolerance to at least 3 generic alternatives for the treatment of partial-onset seizures or 4. Member is stable on Aptiom DAYTRANA 10 MG/9 HR PATCH DAYTRANA ST Coverage will be provided when the following have been met: 1. Diagnosis of ADHD. 2.? 6 years of age 3. Treatment failure or intolerance to one generic methylphenidate product and one generic amphetamine product (one of which must be a longacting formulation). DAYTRANA 15 MG/9 HR PATCH DAYTRANA ST Coverage will be provided when the following have been met: 1. Diagnosis of ADHD. 2.? 6 years of age 3. Treatment failure or intolerance to one generic methylphenidate product and one generic amphetamine product (one of which must be a longacting formulation). DAYTRANA 20 MG/9 HOUR PATCH DAYTRANA ST Coverage will be provided when the following have been met: 1. Diagnosis of ADHD. 2.? 6 years of age 3. Treatment failure or intolerance to one generic methylphenidate product and one generic amphetamine product (one of which must be a longacting formulation). DAYTRANA 30 MG/9 HOUR PATCH DAYTRANA ST Coverage will be provided when the following have been met: 1. Diagnosis of ADHD. 2.? 6 years of age 3. Treatment failure or intolerance to one generic methylphenidate product and one generic amphetamine product (one of which must be a longacting formulation). DESVENLAFAXINE ER 100 MG TAB DESVENLAFAXINE ER QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. DESVENLAFAXINE ER 50 MG TAB DESVENLAFAXINE ER QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. DESVENLAFAXINE FUM ER 100 MG DESVENLAFAXINE FUMARATE ER QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. 21

22 Step Therapy Information Central Nervous System Agents DESVENLAFAXINE FUM ER 50 MG DESVENLAFAXINE FUMARATE ER QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. FETZIMA MG TITRATION PAK FETZIMA QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. FETZIMA ER 120 MG CAPSULE FETZIMA QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. FETZIMA ER 20 MG CAPSULE FETZIMA QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. FETZIMA ER 40 MG CAPSULE FETZIMA QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. FETZIMA ER 80 MG CAPSULE FETZIMA QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. FORFIVO XL 450 MG TABLET FORFIVO XL QL,ST Requires trial and failure of generic bupropion KHEDEZLA ER 100 MG TABLET KHEDEZLA QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. KHEDEZLA ER 50 MG TABLET KHEDEZLA QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. PRISTIQ ER 100 MG TABLET PRISTIQ ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. PRISTIQ ER 25 MG TABLET PRISTIQ ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. PRISTIQ ER 50 MG TABLET PRISTIQ ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. QUILLIVANT XR 25 MG/5 ML SUSP QUILLIVANT XR PA,ST See Prior Authorization Criteria, Coverage will be provided when the following have been met: 1. Diagnosis of ADHD. 2.? 6 years of age 3. Treatment failure or intolerance to one generic methylphenidate product and one generic amphetamine product (one of which must be a longacting formulation). TRINTELLIX 10 MG TABLET TRINTELLIX QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. TRINTELLIX 20 MG TABLET TRINTELLIX QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. 22

23 Step Therapy Information Central Nervous System Agents TRINTELLIX 5 MG TABLET TRINTELLIX QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. VIIBRYD 10 MG TABLET VIIBRYD QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. VIIBRYD 20 MG TABLET VIIBRYD QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. VIIBRYD 40 MG TABLET VIIBRYD QL,ST Requires trial and failure of at least 2 generic or preferred antidepressant agents. Dermatological ELIDEL 1% CREAM ELIDEL ST Requires trial and failure of a topical corticosteroid or calcipotriene SORILUX 0.005% FOAM SORILUX PA,ST PA Required, Requires trial and failure of a topical corticosteroid or calcipotriene SOOLANTRA 1% CREAM SOOLANTRA QL,ST Coverage will be provided when all of the following have been met: Trial and failure of all of the following: 1. Generic topical metronidazole. 2. Generic topical sulfacetamide 10%-sulfur 5%. 3. Generic oral tetracycline, generic doxycycline or generic minocycline. FINACEA 15% FOAM FINACEA QL,ST Coverage will be provided when all of the following have been met: Trial and failure of all of the following: 1. Generic topical metronidazole. 2. Generic topical sulfacetamide 10%-sulfur 5%. 3. Generic oral tetracycline, generic doxycycline or generic minocycline. MIRVASO 0.33% GEL MIRVASO ST Coverage will be provided when all of the following have been met: Trial and failure of all of the following: 1. Generic topical metronidazole. 2. Generic topical sulfacetamide 10%-sulfur 5%. 3. Generic oral tetracycline, generic doxycycline or generic minocycline. 23

24 Step Therapy Information Dermatological MIRVASO 0.33% GEL PUMP MIRVASO ST Coverage will be provided when all of the following have been met: Trial and failure of all of the following: 1. Generic topical metronidazole. 2. Generic topical sulfacetamide 10%-sulfur 5%. 3. Generic oral tetracycline, generic doxycycline or generic minocycline. ZITHRANOL 1% SHAMPOO ZITHRANOL PA,ST PA Required, Requires trial and failure of a topical corticosteroid or calcipotriene Dermatological - Anti-infectives ECOZA 1% FOAM ECOZA PA,ST See Prior Authorization Criteria, Requires two 30-day trials of a generic topical antifungal ERTACZO 2% CREAM ERTACZO ST Requires two 30-day trials of a generic topical antifungal EXELDERM 1% CREAM EXELDERM ST Requires two 30-day trials of a generic topical antifungal EXELDERM 1% SOLUTION EXELDERM ST Requires two 30-day trials of a generic topical antifungal JUBLIA 10% TOPICAL SOLUTION JUBLIA PA,ST See Prior Authorization Criteria, Requires two 30-day trials of a generic topical antifungal KERYDIN 5% TOPICAL SOLUTION KERYDIN PA,ST See Prior Authorization Criteria, Requires two 30-day trials of a generic topical antifungal LUZU 1% CREAM LUZU PA,ST See Prior Authorization Criteria, Requires two 30-day trials of a generic topical antifungal VUSION OINTMENT VUSION ST Requires two 30-day trials of a generic topical antifungal XOLEGEL 2% GEL XOLEGEL PA,ST See Prior Authorization Criteria, Requires two 30-day trials of a generic topical antifungal Dermatological - Antipsoriatics ENSTILAR 0.005%-0.064% FOAM ENSTILAR PA,QL,ST PA Required, Requires trial and failure of a topical corticosteroid or calcipotriene TACLONEX 0.005%-0.064% SUSPENSION TACLONEX PA,ST PA Required, Requires trial and failure of a topical corticosteroid or calcipotriene Diabetic Therapy ALOGLIPTIN 12.5 MG TABLET ALOGLIPTIN QL,ST Requires trial and failure of Januvia and Onglyza 24

25 Step Therapy Information Diabetic Therapy ALOGLIPTIN 25 MG TABLET ALOGLIPTIN QL,ST Requires trial and failure of Januvia and Onglyza BYDUREON 2 MG VIAL BYDUREON PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent FARXIGA 10 MG TABLET FARXIGA PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent FARXIGA 5 MG TABLET FARXIGA PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent JANUVIA 100 MG TABLET JANUVIA QL,ST Requires trial and failure of metformin or a metformin combination agent ADLYXIN MCG STARTER PACK ADLYXIN ST Requires trial and failure of metformin or a metformin combination agent ADLYXIN 20 MCG MAINTENANCE PK ADLYXIN ST Requires trial and failure of metformin or a metformin combination agent ALOGLIPTIN 6.25 MG TABLET ALOGLIPTIN QL,ST Requires trial and failure of Januvia and Onglyza BYDUREON 2 MG PEN INJECT BYDUREON PEN PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent BYETTA 10 MCG DOSE PEN INJ BYETTA PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent BYETTA 5 MCG DOSE PEN INJ BYETTA PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent INVOKANA 100 MG TABLET INVOKANA PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent INVOKANA 300 MG TABLET INVOKANA PA,ST See Prior Authorization Criteria, Requires trial and failure of metformin or a metformin combination agent JANUVIA 25 MG TABLET JANUVIA QL,ST Requires trial and failure of metformin or a metformin combination agent JANUVIA 50 MG TABLET JANUVIA QL,ST Requires trial and failure of metformin or a metformin combination agent 25

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

2015 Step Therapy Prior Authorization Medical Necessity Guidelines Tufts Health Unify 2015 Step Therapy Prior Authorization Medical Necessity Guidelines Effective: 01/01/2015 Updated: 10/01/2015 Tufts Health Plan P.O. Box 9194 Watertown, MA 02471-9194 Phone: 855-393-3154

More information

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication. ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE

More information

Step Therapy Criteria

Step Therapy Criteria Tier 5 Formulary Step Therapy 2016 Updated: 05/24/2016 Effective: 06/01/2016 What is Step Therapy? Some prescription drugs require step therapy (ST). In some cases, the plan requires you to first try certain

More information

2018 Step Therapy FID 18088

2018 Step Therapy FID 18088 2018 Step Therapy FID 18088 Step Therapy ANTIDEPRESSANTS, SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS LEON 2018 Desvenlafaxine Er Fetzima Fetzima Titration Pack Khedezla Paxil SUSP Pristiq Trintellix

More information

ADHD STIMULANTS-S(SHC)

ADHD STIMULANTS-S(SHC) Step Therapy Simply Health Care 2014 Formulary ID: 14406 Version: 14 Last Updated: 08/01/2014 ADHD STIMULANTS-S(SHC) Daytrana Focalin Xr Strattera Patient needs to have a paid claim for one Step 1 drug

More information

ATYPICAL ANTIPSYCHOTICS

ATYPICAL ANTIPSYCHOTICS Step Therapy CareOregon 2018 Last Updated: 07/27/2018 ATYPICAL ANTIPSYCHOTICS Fanapt Fanapt Titration Pack Paliperidone Er Vraylar The following criteria applies to members who newly start on the drug:

More information

Step Therapy Medications

Step Therapy Medications Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,

More information

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009 2018 2018 Simply Step Therapy Document September 2018 Aptiom APTIOM 200 MG TABLET APTIOM 400 MG TABLET Y0114_18_33074_I_009 APTIOM 600 MG TABLET APTIOM 800 MG TABLET Criteria If the patient has tried a

More information

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009 2018 PDP Premier Step Therapy Document September 2018 Aggrenox Y0114_18_33144_I_009 aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.

More information

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST) Plan Year 2016 CCHP Senior Program (HMO) Step Therapy Criteria (ST) Step Therapy: In some cases, CCHP Senior Program (HMO) requires you to first try certain drugs to treat your medical condition before

More information

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018 TEST Network Health Insurance Corporation NetworkCares Step Therapy Last Updated 11/2018 ANTICONVULSANT THERAPY Aptiom Banzel Briviact Celontin Dilantin 30 Mg Capsule Equetro Fycompa 0.5 Mg/ml Oral Susp

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.

More information

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.

More information

ALLERGIC CONJUNCTIVITIS AGENTS

ALLERGIC CONJUNCTIVITIS AGENTS 2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops

More information

BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET

BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET BYSTOLIC BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET authorization for a Step 2 drug may be given. Step 1 Drug(s): generic beta-blockers and/or combinations,

More information

2018 Step Therapy Criteria

2018 Step Therapy Criteria 2018 Step Therapy Criteria ANGIOTENSIN RECEPTOR BLOCKERS... 2 ANTIDEPRESSANTS... 3 ANTIDEPRESSANTS, MISCELLANEOUS... 4 ANTIDEPRESSANTS, OTHER... 5 ANTIDIABETIC AGENTS... 6 ANTIGOUT AGENTS... 7 ANTIHYPERTENSIVE

More information

Step Therapy Requirements. Effective: 1/1/2019

Step Therapy Requirements. Effective: 1/1/2019 Effective: 1/1/2019 Updated 1/2019 AMANTADINE ER Sharp Health Plan (HMO) OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE

More information

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS ANTIDIABETIC AGENTS - MISCELLANEOUS GLYXAMBI 10 MG-5 MG GLYXAMBI 25 MG-5 MG INVOKAMET 150 MG-1,000 MG INVOKAMET 150 MG-500 MG INVOKAMET 50 MG-1,000 MG INVOKAMET 50 MG-500 MG INVOKAMET XR 150 MG-1,000 MG,

More information

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015 2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Last Updated 11/1/2015 APLENZIN TAB 174MG, 348MG, 522MG Step Therapy requires trial of bupropion SR or bupropion XL in previous 180

More information

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500

More information

Step Therapy Requirements. Effective: 05/01/2018

Step Therapy Requirements. Effective: 05/01/2018 Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG

More information

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria ANTIDEPRESSANTS Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet

More information

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details 5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS

More information

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda

More information

SmithRx Standard Formulary Step Therapy List

SmithRx Standard Formulary Step Therapy List SmithRx Standard Formulary Step Therapy List Revised: January 27, 2017 The following medications require prior use of at least one other medication for coverage. Please note that any plan-specific customizations

More information

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 11/01/2018 Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK

More information

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG FYCOMPA 0.5 MG/ML ORAL SUSPENSION FYCOMPA 10 MG FYCOMPA 12 MG FYCOMPA

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET APTIOM 800 MG TABLET BANZEL 200 MG TABLET BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG TABLET FYCOMPA 0.5 MG/ML ORAL SUSPENSION

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension

More information

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements Effective 7/1/2018 Updated 6/2018 BRAND NAME ANTIDEPRESSANTS APLENZIN

More information

Step Therapy Requirements

Step Therapy Requirements Step Therapy Requirements Denver Health Medicare Choice (HMO SNP)/Medicare Select (HMO) Effective: 09/01/2017 Updated 08/2017 ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet

More information

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017 VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 01/01/2017 Updated 12/23/2016 ANTICONVULSANTS Aptiom 200 mg tablet Potiga 200 mg tablet Aptiom 400 mg tablet Potiga 300 mg tablet Aptiom

More information

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum.

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, HealthNow New York Inc. requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition.

More information

FirstCarolinaCare Insurance Company. Step Therapy Requirements

FirstCarolinaCare Insurance Company. Step Therapy Requirements FirstCarolinaCare Insurance Company Step Therapy Requirements Effective: 12/01/2018 ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION

More information

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E Santa Clara Family Health Plan Cal MediConnect Formulary List of Step Therapy Requirements Effective: 12/01/2018 13027.12E ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS. 1 ANTICONVULSANTS

More information

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Providers may call the Pharmacy Help Desk at 800-641-8921 for more information or questions about criteria. The formulary may change

More information

ANTICONVULSANT THERAPY

ANTICONVULSANT THERAPY Network Health Insurance Corporation NetworkCares Step Therapy Last Updated: 7/2017 ANTICONVULSANT THERAPY Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200

More information

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5

More information

2017 Step Therapy Criteria

2017 Step Therapy Criteria FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.

More information

2019 Simply Step Therapy Document

2019 Simply Step Therapy Document Aggrenox 2019 Simply Step Therapy Document AGGRENOX 25 MG-200 MG CAPSULE, EXTENDED aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.

More information

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6 CHRISTUS Health Plan Generations (HMO) 2017 Step Therapy Criteria H1189_PC57 Accepted 11/17/2016 1 Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE

More information

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL* Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

More information

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0. ANTI DIABETICS BYDUREON 2 MG SUBCUTANEOUS JANUVIA 25 MG TABLET EXTENDED RELEASE SUSPENSION JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET

More information

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires

More information

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE ADHD STIMULANTS - SCORE Step Therapy Strattera Patient needs to have a paid claim for two generic formulary ADHD stimulant medications. Formulary ID# 00017034 Last Updated: 08/01/2017 1 ALPHA GLUCOSIDASE

More information

Step Therapy Requirements. Effective: 03/01/2015

Step Therapy Requirements. Effective: 03/01/2015 Effective: 03/01/2015 Updated 02/2015 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA OXTELLAR XR POTIGA QUDEXY

More information

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE Step Therapy Trillium 5 Tier Effective Date: 12/01/2017 Approval Date: 10/24/2017 ADHD STIMULANTS - SCORE Strattera Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant

More information

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO) Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO) Step Therapy Requirements Effective 4/1/2019 Updated 3/2019 BRAND

More information

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements 2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for

More information

FirstCarolinaCare Insurance Company Step Therapy Requirements

FirstCarolinaCare Insurance Company Step Therapy Requirements ANALGESICS, NARCOTICS KADIAN MORPHINE SULFATE ER PRIOR CLAIM FOR MORPHINE SULFATE SUSTAINED ACTION TABLET (MS CONTIN) WITHIN THE PAST 120 DAYS. ANTIBACTERIALS (EENT) BESIVANCE PRIOR CLAIM FOR CIPROFLOXACIN

More information

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements 2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for

More information

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if

More information

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements 2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for

More information

Step Therapy Requirements. Effective: 12/01/2016

Step Therapy Requirements. Effective: 12/01/2016 Effective: 12/01/2016 H2986_PD_049 Updated 11/2016 ALPHA 1-PROTEINASE INHIBITOR GLASSIA PRIOR CLAIM FOR ARALAST NP OR ZEMAIRA WITHIN THE PAST 120 DAYS. ANALGESICS, NARCOTICS KADIAN MORPHINE SULFATE ER

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Step Therapy Individual and Family Plan Table of Contents Coverage Policy... 1 General Background... 5 References... 5 Effective Date... 3/15/2018 Next Review

More information

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements 2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for

More information

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017 Effective: 01/01/2017 Updated 11/2016 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA GABITRIL OXTELLAR XR POTIGA

More information

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017) ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN

More information

High-Cost Drug Exclusions

High-Cost Drug Exclusions Pharmacy Services High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

**CRITERIA UNDER CMS REVIEW**

**CRITERIA UNDER CMS REVIEW** **CRITERIA UNDER CMS REVIEW** ANTICONVULSANTS APTIOM TABLET 200 MG APTIOM TABLET 400 MG APTIOM TABLET 600 MG APTIOM TABLET 800 MG BANZEL SUSPENSION 40 MG/ML BANZEL TABLET 200 MG BANZEL TABLET 400 MG BRIVIACT

More information

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017) ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN

More information

High-Cost Drug Exclusions

High-Cost Drug Exclusions PHARMACY SERVICES High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at

More information

Step Therapy Criteria 2019

Step Therapy Criteria 2019 Step Therapy 2019 For information on obtaining an updated coverage determination or an exception to a coverage determination please call Freedom Health Member Services at 1-800-401-2740 or, for TTY/TDD

More information

2017 Step Therapy (ST) Criteria

2017 Step Therapy (ST) Criteria 2017 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that

More information

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018. ALBUTEROL - SCORE Ventolin Hfa Trial of ProAir Formulary ID 18354, Version 15 1 ANTIDEPRESSANTS - SCORE Aplenzin Desvenlafaxine Er TB24 100MG, 50MG Emsam Fetzima Fetzima Titration Pack Trial of two of

More information

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018. ALBUTEROL - SCORE Ventolin Hfa Trial of ProAir Formulary ID: 18349, Ver.15 Last Updated 10/23/2018 Effective Date: 11/1/2018 1 ANTIDEPRESSANTS - SCORE Aplenzin Desvenlafaxine Er TB24 100MG, 50MG Emsam

More information

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019 Step Therapy Requirements Effective April 1, 2019 ANTIEMETICS STEP Sancuso 3.1 mg/24 hour transdermal patch Zuplenz 4 mg oral soluble film Zuplenz 8 mg oral soluble film COVERAGE OF CERTAIN BRAND NAME

More information

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011 Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 211 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical effectiveness

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule CHRISTUS Health Plan Generations (HMO) CHRISTUS Health Plan Generations Plus (HMO) 2018 Premier Performance Standard Step Therapy PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT SOME OF THE DRUGS

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, BlueCross BlueShield of WNY requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition.

More information

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018 Step Therapy Requirements Effective April 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone

More information

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019 Step Therapy Date Effective: April 1, 2019 ANTICONVULSANTS APTIOM TABLET 200 MG ORAL APTIOM TABLET 400 MG ORAL APTIOM TABLET 600 MG ORAL APTIOM TABLET 800 MG ORAL BANZEL SUSPENSION 40 MG/ML ORAL BANZEL

More information

2018 Step Therapy (ST) Criteria

2018 Step Therapy (ST) Criteria 2018 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that

More information

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018 Step Therapy Requirements Effective June 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone

More information

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum.

More information

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019 VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 04/01/2019 Updated 03/2019 AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED

More information

ALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017

ALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone 15 mg tablet alogliptin 12.5 mg-pioglitazone

More information

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018. ALBUTEROL - SCORE Ventolin Hfa Trial of ProAir Formulary ID 18351, Version 15 1 ANTIDEPRESSANTS - SCORE Desvenlafaxine Er TB24 100MG, 50MG Emsam Fetzima Fetzima Titration Pack Trial of two of the following

More information

CONTENTS SECTION 1 SECTION

CONTENTS SECTION 1 SECTION CONTENTS SECTION 1 Foundations of Drug Therapy 1 CHAPTER 1 Introduction to Pharmacology 3 A Message to Students 3 Pharmacology and Drug Therapy 3 Understanding Grouping and Naming of Drugs 4 Prescription

More information